<?xml version="1.0" encoding="UTF-8"?>
<p>Male Balb/c albino mice (20â€“25 g) were held in standard conditions in the Animal Facility, College of Pharmacy, King Abdulaziz University, and provided with standard laboratory food and water. All study procedures were approved by the Research Ethical Committee of King Abdulaziz University, Saudi Arabia (reference number PH-116-40), which follows the National Institutes of Health (NIH) guidelines. Mice were divided into 5 groups (
 <italic>n</italic> = 8/each group) and were treated as follows: 
 <bold>
  <italic>control group</italic>
 </bold>: mice were given the vehicle once daily for 5 days; 
 <bold>
  <italic>LPS group</italic>
 </bold>: to induce acute lung injury, we injected LPS (10 mg/kg) intraperitoneally, as previously described [
 <xref rid="B4-plants-09-01620" ref-type="bibr">4</xref>]; 
 <bold>
  <italic>EC + LPS groups</italic>
 </bold>: 2 animal groups that were orally administered EC at 2 different dose levels (25 and 50 mg/kg) for 5 days prior to LPS injection; dexamethasone 
 <bold>(
  <italic>DEX</italic>) 
  <italic>+ LPS</italic> group
 </bold>: a positive control group where mice were administered dexamethasone (5 mg/kg) for 5 days prior to LPS injection. The dose of dexamethasone was selected on the basis of previous studies [
 <xref rid="B23-plants-09-01620" ref-type="bibr">23</xref>,
 <xref rid="B24-plants-09-01620" ref-type="bibr">24</xref>]
</p>
